Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 3
2002 2
2003 1
2004 3
2005 3
2006 2
2007 1
2008 2
2009 1
2010 2
2011 3
2012 6
2013 2
2014 2
2015 4
2017 2
2018 4
2020 11
2021 8
2022 16
2023 8
2024 8
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts.
Gervais A, Trespidi F, Ferrari A, Rovida F, Marchal A, Croce S, Cassaniti I, Moratti M, Uhrlaub JL, Florian DM, Stiasny K, Burdino E, Angelini M, Bizien L, Lilleri D, Codullo V, Freund T, Paran Y, Gadoth A, Biran R, Mancon A, Lucca C, Vogiatzis S, Pacenti M, Aubart M, Zecca M, Comoli P, Avanzini MA, Fellay J, Piralla A, Conti F, Dolci A, Barzon L, Ghisetti V, Lazzarotto T, Cereda D, Aiuti A, Jouanguy E, Bastard P, MacDonald MR, Rice CM, Puel A, Abel L, Rossini G, Mileto D, Simonin Y, Nagy A, Hagin D, Murray KO, Baldanti F, Aberle JH, Cobat A, Zhang SY, Casanova JL, Borghesi A. Gervais A, et al. Among authors: aberle jh. J Hum Immun. 2026 Mar 13;2(3):e20250189. doi: 10.70962/jhi.20250189. eCollection 2026 May 4. J Hum Immun. 2026. PMID: 41836040 Free PMC article.
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts.
Gervais A, Trespidi F, Ferrari A, Rovida F, Marchal A, Croce S, Cassaniti I, Moratti M, Uhrlaub JL, Florian DM, Stiasny K, Burdino E, Angelini M, Bizien L, Lilleri D, Codullo V, Freund T, Paran Y, Gadoth A, Biran R, Mancon A, Lucca C, Vogiatzis S, Pacenti M, Aubart M, Zecca M, Comoli P, Avanzini MA, Fellay J, Piralla A, Conti F, Dolci A, Barzon L, Ghisetti V, Lazzarotto T, Cereda D, Aiuti A, Jouanguy E, Bastard P, MacDonald MR, Rice CM, Puel A, Abel L, Rossini G, Mileto D, Simonin Y, Nagy A, Hagin D, Murray KO, Baldanti F, Aberle JH, Cobat A, Zhang SY, Casanova JL, Borghesi A. Gervais A, et al. Among authors: aberle jh. medRxiv [Preprint]. 2025 Sep 4:2025.08.31.25334556. doi: 10.1101/2025.08.31.25334556. medRxiv. 2025. Update in: J Hum Immun. 2026 Mar 13;2(3):e20250189. doi: 10.70962/jhi.20250189. PMID: 40950468 Free PMC article. Updated. Preprint.
Seroprevalence against measles, Austria, stratified by birth years 1922 to 2024.
Springer DN, Borsodi C, Camp JV, Redlberger-Fritz M, Holzmann H, Kundi M, Aberle JH, Stiasny K, Weseslindtner L. Springer DN, et al. Among authors: aberle jh. Euro Surveill. 2025 Apr;30(16):2400684. doi: 10.2807/1560-7917.ES.2025.30.16.2400684. Euro Surveill. 2025. PMID: 40276882 Free PMC article.
Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity.
Florian DM, Bauer M, Popovitsch A, Fae I, Springer DN, Graninger M, Traugott M, Weseslindtner L, Aberle SW, Fischer G, Kundi M, Stiasny K, Zoufaly A, Landry SJ, Aberle JH. Florian DM, et al. Among authors: aberle jh. Front Immunol. 2025 Mar 21;16:1501704. doi: 10.3389/fimmu.2025.1501704. eCollection 2025. Front Immunol. 2025. PMID: 40191213 Free PMC article.
Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis identify a possible postacute sequel of COVID-19.
Röttele F, Zollner A, Mogler C, Yuksel M, Arikan C, Karl V, Aberle JH, Aberle SW, Kogler H, Vécsei A, Vodopiutz J, Salié H, Gräser A, Krimmel L, Martin P, Lurz E, Maier FI, Woelfle L, Nobre S, Goncalves I, Kern L, Schwemmle M, Boettler T, Hofmann M, Hasselblatt P, Thimme R, Tilg H, Müller T, Vogel GF, Bengsch B. Röttele F, et al. Among authors: aberle jh. Gut. 2025 Aug 7;74(9):1486-1499. doi: 10.1136/gutjnl-2024-333880. Gut. 2025. PMID: 40187893 Free PMC article.
Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency : A prospective controlled open-label trial.
Vossen MG, Kartnig F, Mrak D, Simader E, Stiasny K, Kain R, Perkmann T, Haslacher H, Aberle JH, Heinz LX, Sieghart D, Burgmann H, Aletaha D, Scheinecker C, Bonelli M, Göschl L. Vossen MG, et al. Among authors: aberle jh. Wien Klin Wochenschr. 2024 Nov;136(21-22):598-607. doi: 10.1007/s00508-024-02459-6. Epub 2024 Oct 24. Wien Klin Wochenschr. 2024. PMID: 39446203 Free PMC article. Clinical Trial.
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients.
Gervais A, Marchal A, Fortova A, Berankova M, Krbkova L, Pychova M, Salat J, Zhao S, Kerrouche N, Le Voyer T, Stiasny K, Raffl S, Schieber Pachart A, Fafi-Kremer S, Gravier S, Robbiani DF, Abel L, MacDonald MR, Rice CM, Weissmann G, Kamal Eldin T, Robatscher E, Erne EM, Pagani E, Borghesi A, Puel A, Bastard P, Velay A, Martinot M, Hansmann Y, Aberle JH, Ruzek D, Cobat A, Zhang SY, Casanova JL. Gervais A, et al. Among authors: aberle jh. J Exp Med. 2024 Oct 7;221(10):e20240637. doi: 10.1084/jem.20240637. Epub 2024 Sep 24. J Exp Med. 2024. PMID: 39316018 Free PMC article.
97 results